CA-ATLASSIAN
4.3.2014 17:04:44 CET | Business Wire | Pressemeddelelse
Atlassian , a leading provider of collaboration software for teams, today announced Atlassian Connect - an extensible new framework for developers to build add-ons that deeply integrate with Atlassian JIRA OnDemand and Atlassian Confluence OnDemand, the company's cloud-based issue tracking and collaboration offerings. Developers can offer these add-ons to Atlassian's 33,000 customers via the Atlassian Marketplace , a proven ecosystem of more than 1,500 commercial and free add-ons. Since the Atlassian Marketplace launched in 2012, third party add-on developers who have sold products via the platform have earned more than $20 million.
"Customer demand for customized add-ons to our cloud-based JIRA and Confluence offerings has been incredible," said Nick Wade, director of Atlassian Marketplace. "With our next generation development framework – Atlassian Connect – third-party developers can now easily create secure and scalable add-ons for millions of Atlassian cloud-based customers and sell their products via our marketplace. We’re thrilled to help fellow developers build their own businesses."
Click to tweet : "Announcing @Atlassian Connect, the next generation of add-ons for No. JIRA and No. Confluence OnDemand http://ow.ly/ucD4I"
The new Atlassian Connect framework, built on common web standards like REST APIs and JWT authentication, offers additional modules for developers to integrate add-ons directly into Atlassian applications using the technology stack of their choice. Third-party partners like Zendesk, Lucidchart, Gliffy, Zephyr, and Comalatech are among the early adopters of Atlassian Connect. Today 15 publicly available add-ons for Atlassian JIRA and Confluence OnDemand are already in use by more than 600 companies.
"The streamlined discovery and procurement experience offered by marketplaces accelerates the consumption of applications - making it a win/win for both customer and developer, as the mobile market has more than adequately demonstrated," said Stephen O'Grady, principal analyst with RedMonk. "Atlassian has invested heavily in this area, and with Atlassian Connect is attempting to dramatically expand the reach of its Marketplace to the cloud."
"We see Atlassian Connect as an opportunity to re-architect our successful diagramming and mockup tool for JIRA," said Chris Kohlhardt, CEO of Gliffy. "Based on Atlassian Connect, the next version of Gliffy for JIRA OnDemand will maintain the same intuitive interface and we'll be able to deploy product improvements instantly."
Rich platform for developers
Atlassian Connect provides rich user interface integration and continuous two-way communication to create smoother end-to-end experiences for customers. Specifically, Atlassian Connect offers:
- Simple descriptors: Any web application – written in any language – can become an Atlassian Connect add-on by providing a simple JSON file to describe itself to Atlassian applications. Atlassian has already built client libraries for node.js and the Play framework to make getting started even easier.
- User interface modules: Atlassian Connect provides almost two dozen different UI integration points, such as issue panels, page macros, and fullscreen pages for add-ons to insert content directly into the Atlassian application.
- Two-way communication : Atlassian Connect add-ons can pull data and push data back using JIRA or Confluence's REST APIs, listen for events with webhooks, and recognize different users via JWT authentication.
Training/Availability
Atlassian will provide extensive training and discussion of Atlassian Connect at its upcoming eighth annual developer conference, AtlasCamp , to be held June 3-5 in Berlin, Germany. For more information, go to www.atlassian.com/AtlasCamp . Developers interested in building Atlassian Connect add-ons for public distribution or private use can access developer tutorials and documentation at connect.atlassian.com .
Newly available add-ons for JIRA and Confluence OnDemand built using Atlassian Connect include:
- Zendesk for JIRA: Seamlessly escalate Zendesk tickets to JIRA to keep customer support, developers, and product managers all in sync
- EazyBI for JIRA: A powerful business intelligence tool with drag-and-drop creation of pivot tables and charts based on JIRA data
- Canvas for Confluence and JIRA: Interactive boards help teams collaborate visually: create issues or pages, drag to organize by field attribute or label, and filter
- Harvest Time Tracking for JIRA: Integration between JIRA and the Harvest time tracking platform so users can track time on JIRA issues from within JIRA
- Ink File Picker for Confluence: Allows Confluence users to attach files to pages from over a dozen cloud storage services, including Box, Dropbox, Google Drive, and SkyDrive
- Aha! Product Roadmaps for JIRA: Create product strategy and visual roadmaps in Aha! and move epics and stories into JIRA to be developed
Developer tutorials and documentation are available at connect.atlassian.com .
About Atlassian
Atlassian products help innovators everywhere plan, build and launch great software. More than 33,000 large and small organizations – including Citigroup, eBay, Coca-Cola, Netflix and United Airlines – use Atlassian’s issue tracking, collaboration and software-development products to work smarter and deliver quality results on time. Learn more at http://atlassian.com .
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20140304005805/en/
Contact:
Atlassian
Aaron Forman, 415-701-1110 ext. 4450
Link:
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
RevolKa Reimagines Antibody Engineering with "RevoAb®"1.4.2026 06:30:00 CEST | Press release
A Same-day Sequence Optimization Service to Elevate Antibody Expression Levels by RevolKa’s advanced AI Protein Engineering Engine RevolKa Ltd. (RevolKa), a venture-backed biotech company providing an advanced AI protein engineering technology platform, called aiProtein®, is pleased to announce the official global launch of RevoAb®, an innovative and quick online service for antibody sequence optimization to solve challenges in physicochemical properties, especially antibodyyields. RevoAb®:The Next-Gen AI Antibody Design Since December 2023, RevolKa has provided an antibody optimization services utilizing aiProtein®. The newly launched RevoAb® is a quick intuitive online antibody sequence optimization service that integrates RevolKa’s core technology—the "Refined Naturalness Framework Engineering". RevoAb® is designed to generate antibody framework sequences optimized for improved physicochemical properties, especially protein expression levels, without trade-off of affinity. This allo
Global Beauty Market Grows 10% as AI and E-commerce Reshape Consumer Buying1.4.2026 03:00:00 CEST | Press release
Online sales outpace in-store by 6x as digital-first and AI-influenced commerce accelerates globally NielsenIQ (NYSE:NIQ), a global leader in consumer intelligence, today released its State of Beauty 2026 report, showing the global beauty market grew 10% year-on-year, with E-commerce expanding six times faster than in-store sales. The findings highlight a rapid shift to digital-first, AI-influenced commerce across key global markets. As consumer expectations evolve toward convenience, personalization, and seamless digital experiences, beauty brands are under increasing pressure to adapt. From AI-powered product discovery to social commerce and livestream shopping, the path to purchase is becoming more dynamic—requiring brands to move faster and engage consumers across an increasingly complex ecosystem. Key findings from the State of Beauty 2026 report: Global beauty sales grew 10% year-over-year, driven by strong digital acceleration E-commerce is growing 6x faster than in-store sales,
bet365 Partners with TestMu AI to Accelerate Global Release Velocity with Agentic AI Quality Engineering31.3.2026 19:01:00 CEST | Press release
Streamlines Hillside Technology testing across browsers and mobile devices while supporting rapid expansion into regulated markets. TestMu AI (Formerly LambdaTest), the world's first full-stack Agentic AI Quality Engineering platform, today announced that Hillside Technology Limited, the technology powerhouse behind global online gambling leader bet365, has adopted its platform to unify software testing and support hundreds of weekly production releases. The global online gaming industry is currently experiencing a massive shift, with the market projected to exceed $150 billion by 2030. As mobile gaming becomes the primary touchpoint for users, the technical complexity of delivering a seamless, low-latency experience has grown exponentially. For industry giants like bet365, the need to validate software across an infinite matrix of hardware, screen resolutions, and OS versions is a mission-critical requirement. This partnership ensures that, as gaming becomes more mobile-centric, bet36
IFF Secures First Heart Health Claim for Soy Protein in Australia and New Zealand31.3.2026 16:00:00 CEST | Press release
Regulatory milestone opens heart health growth opportunities for food and beverage manufacturers IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients and health & biosciences announced today that a new heart health claim for isolated soy protein has been accepted by the Food Standards Australia New Zealand (FSANZ). The approval enables food and beverage manufacturers in Australia and New Zealand to link soy protein consumption with healthy blood cholesterol levels. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330523416/en/ First heart health claim approved for soy protein in Australia and New Zealand. “For decades, IFF has invested in the science behind soy protein and its role in supporting cardiovascular health,” said Tony Andrew, vice president of protein solutions for IFF Food Ingredients. “This approved claim validates years of rigorous research and collaboration. With our deep expertise in ing
Sub-Q Bionics Closes $1.5M Pre-Seed Round to Advance Next-Generation Solution for Lymphedema Care31.3.2026 15:26:00 CEST | Press release
Sub-Q Bionics, a medical device company developing next-generation solutions to improve care for patients living with lymphedema, today announced the successful close of its $1.5 million pre-seed funding round. The round includes investment from Mayo Clinic and Yeda, the technology transfer company of the Weizmann Institute of Science, as well as several private investors. The Israel Innovation Authority also provided matching funds. The funding will enable Sub-Q Bionics to continue to develop its novel bionic lymph node technology designed to transform how lymphedema is managed, based on scientific innovations from the Weizmann Institute and Shamir Medical Center. The system aims to provide a solution to manage fluid with a subcutaneous implant that will allow patients freedom of movement, automatic fluid management and reduction of symptoms such as pain and swelling. Lymphedema affects millions of patients worldwide, especially breast cancer survivors, and remains significantly under
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum